股本结构

单位:万股
公告日期 2025-08-08 2025-05-29 2025-05-22 2025-05-09 2025-03-21 2024-11-29
证券总股本 200.26 197.51 195.39 195.20 195.20 174.34
普通股本 200.26 197.51 195.39 195.20 195.20 174.34
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2025-06-30 2025-05-27 2025-05-22 2025-03-31 2024-12-31 2024-11-25
注释:中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本(万股) 变动后优先股(万股) 变动原因 变动日期
2025-08-08 200.26 未披露
更多>>
From March 31, 2025 to June 30, 2025 Issuance of vested RSUs, net of shares held back to offset tax
2025-06-30
2025-05-29 197.51 未披露 定期报告 2025-05-27
2025-05-22 195.39 未披露 定期报告 2025-05-22
2025-05-09 195.20 未披露
更多>>
From January 1,2025 to March 31,2025 Cancellation of common shares
2025-03-31
2025-03-21 195.20 未披露
更多>>
From January 1, 2024 to December 31, 2024 Issuance of Common Stock and Pre-Funded Warrants through public offering Issuance of held-back shares from Sinclair acquisition Cashless exercise of High Trail Warrants Issuance of vested RSUs, net of shares held back to offset tax Exercise of Pre-Funded Warrants Issuance of common shares (IONIC Stock Subscription Payable) Exercise of liability classified warrants, net of forfeitures Exercise of Placement Agent Warrants Issuance of Common Stock in connection with private placement, net Senorita Acquisition Issuance of vested RSUs Stock split share adjustment Conversion of Convertible Note
2024-12-31
2024-11-29 174.34 未披露 定期报告 2024-11-25
2024-11-14 152.97 未披露 定期报告 2024-11-14
2024-11-07 133.15 未披露 定期报告 2024-10-30
2024-10-23 133.18 未披露 定期报告 2024-10-09
2024-10-04 133.18 未披露
更多>>
a 1-for-15 reverse stock split of the Company’s common stock
2024-10-08
2024-09-06 1997.73 未披露 定期报告 2024-09-03
2024-08-14 1423.04 未披露 定期报告 2024-08-14
2024-08-14 1423.00 未披露
更多>>
From March 31, 2024 to June 30, 2024 Exercise of Prefunded Warrants issued through public offering Issuance of vested RSUs, net of shares held back to offset tax
2024-06-30
2024-04-29 1422.94 未披露 定期报告 2024-04-19
2024-04-15 1372.94 未披露 定期报告 2024-04-09
2024-05-21 1327.57 未披露
更多>>
From January 1, 2024 to March 31, 2024 Issuance of Common Stock and prefunded warrants through public offering Issuance of held-back shares from Sinclair acquisition Cashless exercise of High Trail Warrants Exercise of Prefunded Warrants issued through public offering Conversion of Convertible Note Stock split share adjustment
2024-03-31
2024-02-28 750.51 未披露 定期报告 2024-02-28
2024-02-28 684.64 未披露 定期报告 2024-01-25
2024-04-15 170.12 未披露
更多>>
From January 1, 2023 to December 31, 2023 Issuance of Common Stock to Pure Pressure Reverse stock split fractional share settlement Exercise of prefunded warrants in private placement Proceeds from Employee Stock Purchase Plan Shares Issuance of Common Stock through an “at the market” offering, net of fees Issuance of held-back shares to Lab Society Vesting of restricted stock units Conversion of Exchange Note Conversion of Convertible Note
2023-12-31
2023-12-18 170.12 未披露 定期报告 2023-12-01
2024-01-03 165.13 未披露
更多>>
From June 30, 2023 to September 30, 2023 Reverse stock split fractional share settlement
2023-09-30
2023-07-03 162.29 未披露
更多>>
Agrify Corporation announced that the Company’s Board of Directors approved a 1-for-20 reverse stock split, to be effective as of 12:01 a.m. on Wednesday, July 5, 2023.
2023-07-05
2023-02-06 2074.10 未披露 定期报告 2023-01-13
2022-12-16 2076.55 未披露
更多>>
Common stock offered 11,884,615 shares by the company
2022-12-20
2022-12-15 888.09 未披露 定期报告 2022-12-14
2022-11-14 887.64 未披露 定期报告 2022-11-10
2022-10-18 267.10 未披露
更多>>
Agrify Corporation announced that the Company’s Board of Directors approved a 1-for-10 reverse stock split, to be effective as of 12:01 a.m. on Tuesday, October 18, 2022.
2022-10-18
2022-10-17 2671.01 未披露 定期报告 2022-10-17
2022-09-19 2667.85 未披露 定期报告 2022-09-06
2022-08-15 2659.14 未披露 定期报告 2022-08-10
2022-08-15 2659.14 未披露
更多>>
From March 31, 2022 to June 30, 2022 Exercise of options Exercise of warrants
2022-06-30
2022-05-16 2659.14 未披露 定期报告 2022-05-12
2022-04-29 2654.92 未披露 定期报告 2022-04-11
2022-05-16 2654.29 未披露
更多>>
From January 1, 2022 to March 31, 2022 Issuance of Common Stock and warrants in private placement Acquisition of Lab Society Exercise of options Exercise of warrants
2022-03-31
2022-03-31 2654.29 未披露 定期报告 2022-03-24
2022-03-18 2654.29 未披露 定期报告 2022-03-14
2022-02-11 2479.73 未披露 定期报告 2022-02-11
2022-03-31 2220.71 未披露
更多>>
From January 1, 2021 to December 31, 2021 Conversion of Convertible Notes Issuance of common shares in connection with acquisition Issuance of common stock – Initial Public Offering ("IPO"), net of fees Issuance of common stock – Secondary public offering, net of fees Conversion of Preferred A Stock Acquisition of Precision and Cascade Acquisition of PurePressure Exercise of options Exercise of warrants
2021-12-31
2021-11-12 2127.10 未披露 定期报告 2021-11-09
2021-11-12 2126.14 未披露
更多>>
From June 30, 2021 to September 30, 2021 Issuance of common shares in connection with acquisition Exercise of options Exercise of warrants
2021-09-30
2021-08-13 2055.84 未披露 定期报告 2021-08-10
2021-08-13 2037.37 未披露
更多>>
From March 31, 2021 to June 30, 2021 Exercise of options
2021-06-30
2021-05-17 2029.51 未披露
更多>>
From January 1, 2021 To March 31, 2021 Conversion of Convertible Notes Issuance of common stock – Initial Public Offering (“IPO”), net of fees Issuance of common stock – Secondary public offering, net of fees Conversion of Preferred A Stock Exercise of options Exercise of warrants
2021-03-31
2021-04-02 2029.51 未披露 定期报告 2021-03-29
2021-03-22 2005.49 未披露
更多>>
1.The Underwriters exercised the over-allotment option, and on March 22, 2021, the Company closed on the sale of an additional 833,333 shares of common stock for a price of $13.50 per share, less a 7% underwriting commission.The exercise of the over-allotment option brings the total number of shares of common stock sold by the Company in connection with the Offering to 6,388,888 shares and the total net proceeds received in connection with the Offering to approximately $80 million, after deducting underwriting discounts and estimated offering expenses.
2021-03-22
2021-02-19 1922.16 未披露
更多>>
1.Common stock being offered by the company 5,555,555 shares.
2021-02-19
2021-02-11 1366.60 未披露 定期报告 2021-02-11
2021-02-04 1349.18 未披露
更多>>
1.The underwriters exercised the over-allotment option, and on February 4, 2021, the Company closed on the sale of an additional 810,000 shares of common stock for a price of $10.00 per share, less a 7% underwriting commission. The exercise of the over-allotment option brings the total number of shares of common stock sold by the Company in connection with the IPO to 6,210,000 shares and the total net proceeds received in connection with the offering to approximately $57 million, after deducting underwriting discounts and estimated offering expenses.
2021-02-04
2021-01-29 1268.18 未披露
更多>>
1.Common stock being offered by the company 5,400,000 shares
2021-01-28
From March 31, 2025 to June 30, 2025 Issuance of vested RSUs, net of shares held back to offset tax
From January 1,2025 to March 31,2025 Cancellation of common shares
From January 1, 2024 to December 31, 2024 Issuance of Common Stock and Pre-Funded Warrants through public offering Issuance of held-back shares from Sinclair acquisition Cashless exercise of High Trail Warrants Issuance of vested RSUs, net of shares held back to offset tax Exercise of Pre-Funded Warrants Issuance of common shares (IONIC Stock Subscription Payable) Exercise of liability classified warrants, net of forfeitures Exercise of Placement Agent Warrants Issuance of Common Stock in connection with private placement, net Senorita Acquisition Issuance of vested RSUs Stock split share adjustment Conversion of Convertible Note
a 1-for-15 reverse stock split of the Company’s common stock
From March 31, 2024 to June 30, 2024 Exercise of Prefunded Warrants issued through public offering Issuance of vested RSUs, net of shares held back to offset tax
From January 1, 2024 to March 31, 2024 Issuance of Common Stock and prefunded warrants through public offering Issuance of held-back shares from Sinclair acquisition Cashless exercise of High Trail Warrants Exercise of Prefunded Warrants issued through public offering Conversion of Convertible Note Stock split share adjustment
From January 1, 2023 to December 31, 2023 Issuance of Common Stock to Pure Pressure Reverse stock split fractional share settlement Exercise of prefunded warrants in private placement Proceeds from Employee Stock Purchase Plan Shares Issuance of Common Stock through an “at the market” offering, net of fees Issuance of held-back shares to Lab Society Vesting of restricted stock units Conversion of Exchange Note Conversion of Convertible Note
From June 30, 2023 to September 30, 2023 Reverse stock split fractional share settlement
Agrify Corporation announced that the Company’s Board of Directors approved a 1-for-20 reverse stock split, to be effective as of 12:01 a.m. on Wednesday, July 5, 2023.
Common stock offered 11,884,615 shares by the company
Agrify Corporation announced that the Company’s Board of Directors approved a 1-for-10 reverse stock split, to be effective as of 12:01 a.m. on Tuesday, October 18, 2022.
From March 31, 2022 to June 30, 2022 Exercise of options Exercise of warrants
From January 1, 2022 to March 31, 2022 Issuance of Common Stock and warrants in private placement Acquisition of Lab Society Exercise of options Exercise of warrants
From January 1, 2021 to December 31, 2021 Conversion of Convertible Notes Issuance of common shares in connection with acquisition Issuance of common stock – Initial Public Offering ("IPO"), net of fees Issuance of common stock – Secondary public offering, net of fees Conversion of Preferred A Stock Acquisition of Precision and Cascade Acquisition of PurePressure Exercise of options Exercise of warrants
From June 30, 2021 to September 30, 2021 Issuance of common shares in connection with acquisition Exercise of options Exercise of warrants
From March 31, 2021 to June 30, 2021 Exercise of options
From January 1, 2021 To March 31, 2021 Conversion of Convertible Notes Issuance of common stock – Initial Public Offering (“IPO”), net of fees Issuance of common stock – Secondary public offering, net of fees Conversion of Preferred A Stock Exercise of options Exercise of warrants
1.The Underwriters exercised the over-allotment option, and on March 22, 2021, the Company closed on the sale of an additional 833,333 shares of common stock for a price of $13.50 per share, less a 7% underwriting commission.The exercise of the over-allotment option brings the total number of shares of common stock sold by the Company in connection with the Offering to 6,388,888 shares and the total net proceeds received in connection with the Offering to approximately $80 million, after deducting underwriting discounts and estimated offering expenses.
1.Common stock being offered by the company 5,555,555 shares.
1.The underwriters exercised the over-allotment option, and on February 4, 2021, the Company closed on the sale of an additional 810,000 shares of common stock for a price of $10.00 per share, less a 7% underwriting commission. The exercise of the over-allotment option brings the total number of shares of common stock sold by the Company in connection with the IPO to 6,210,000 shares and the total net proceeds received in connection with the offering to approximately $57 million, after deducting underwriting discounts and estimated offering expenses.
1.Common stock being offered by the company 5,400,000 shares